CELZ Stock Analysis
CE
Uncovered
Creative Medical Technology Holdings Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Market cap $B
0.004
Dividend yield
—
Shares outstanding
14.076 B
Creative Medical Technologies, Inc. develops novel regenerative medicine and stem cell technologies. The company is headquartered in Phoenix, Arizona. The company went IPO on 2009-05-01. The firm is focused on immunology, urology, neurology, and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications. The firm conducts its commercial operations through its subsidiary, Creative Medical Technologies, Inc. (CMT). CMT markets and sells its CaverStem and FemCelz disposable kits utilized by physicians to perform autologous procedures that treat erectile dysfunction (ED) and female sexual dysfunction, respectively. Its products include CaverStem, FemCelz, StemSpine, ImmCelz and OvaStem. StemSpine is a regenerative stem cell procedure for the treatment of degenerative disc disease. ImmCelz is a universal donor stem cell therapy for stroke treatment. OvaStem is a stem cell therapy for premature ovarian failure. The company is also focused on the use of its technologies covering treatments for various diseases.